Compare · GDRX vs MEDS

GDRX vs MEDS

Side-by-side comparison of GoodRx Holdings Inc. (GDRX) and DataMeds AI Inc. (MEDS): market cap, price performance, sector, and recent activity on the wire.

Summary

  • GDRX operates in Technology, while MEDS operates in Health Care - the two are in different parts of the market.
  • GDRX is the larger of the two at $1.20B, about 386.3x MEDS ($3.1M).
  • GDRX has been more active in the news (9 items in the past 4 weeks vs 6 for MEDS).
  • GDRX has more recent analyst coverage (25 ratings vs 1 for MEDS).
MetricGDRXMEDS
Company
GoodRx Holdings Inc.
DataMeds AI Inc.
Price
-
-
Market cap
$1.20B
$3.1M
1M return
-
-77.82%
1Y return
-
-98.02%
Industry
EDP Services
Other Pharmaceuticals
Exchange
NASDAQ
NASDAQ
IPO
2020
News (4w)
9
6
Recent ratings
25
1
GDRX

GoodRx Holdings Inc.

GoodRx Holdings, Inc., through its subsidiaries, provides information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including telehealth services. The company serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.

MEDS

DataMeds AI Inc.

DataMEDS AI, Inc. (NASDAQ:MEDS), formerly Wellgistics Health, Inc., is a healthcare company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units through its health information technology platforms to deliver a better experience for consumers and providers. Headquartered in Tampa, Fla., DataMEDS incorporates its EinsteinRx artificial intelligence platform and PharmacyChain blockchain-enabled smart contracts platform into the Health Lives Here mobile application from Tollo Health, LLC, and its pharmacy-related Corexa Health subsidiary provides pharmacy dispensing and pharmacy-related services, including distribution of products developed by Tollo Health. DataMEDS also owns Helomics Corporation, a Pittsburgh, PA -based commercial clinical molecular diagnostics laboratory focused on the ChemoFx Assay chemotherapy selection diagnostics test that aims to help oncologists make chemotherapy treatment decisions.

Latest GDRX

Latest MEDS